How we score weight loss programs

Five dimensions, ten points each, weighted equally. Same framework for every program on the chart. Published here so you can repeat it yourself.

Editor John Samaras

How we choose which programs to include

One bar decides who gets a page. A US patient has to be able to buy a GLP-1 from the program on cash-pay today. Clear that bar and a new program goes to the six vetting checks.

That covers the big telehealth platforms (Hims, Ro, Noom, LifeMD and the like), the compounding pharmacies selling semaglutide and tirzepatide direct, and the manufacturer programs (NovoCare, LillyDirect). 24 today, and the list grows every time a new program launches.

Plenty of sellers stay off. Gray-market sites that skip the prescription, anything that will not ship to the US, and programs with no discoverable price at all. When a program shows its price only after you sign up, we flag that on its row instead of dropping it. The vanishing price is part of the story.

We do not cap the list or rotate programs off to keep it short. Every program that clears the bar stays, on its own page, scored the same way. One leaves only when it shuts down or stops selling.

Missing one, or see a price that looks wrong? Tell us at hello@glpchart.com and we will check it.

How programs get listed

A new program has to pass all six checks.

A month-to-month cash price on the program's own page that says what it includes and the dose it covers. A prepaid plan sold as a monthly rate does not count.
A named US pharmacy, licensed by its state, that fills the prescription.
A published list of the states it serves.
Prescribers licensed in those states.
Every product on the site comes from an ingredient used in an FDA-approved drug or listed on the FDA's compounding bulks list.
A company we can check: a named owner, six months in business and reviews on sites it does not run.

Listing is free and placement is never sold. See what we don't do and our affiliate disclosure.

Write to hello@glpchart.com with the page that shows your price and dose. We read it on a Monday. Either the program goes on the chart or we reply naming the check it missed.

Scoring framework

Every program is scored on five dimensions, weighted equally. The overall score is the simple average of the five.

1How clear the price is

Are all costs published before sign-up?
Are introductory prices clearly distinguished from ongoing prices?
Are mandatory add-ons (lab work, shipping, consult fees) shown upfront?
Is the dose-by-dose cost progression visible?

2How easy it is to cancel

What is the minimum commitment, if any?
How does cancellation work? Is it self-serve or does it require a phone call?
Are there cancellation fees or pro-rated charges?
Are members locked into refilling unused supply?

3How fast you start

How long from sign-up to first prescription?
Is the medical consultation synchronous or asynchronous?
What information must the member provide?
Are required follow-ups clearly scheduled?

4What drugs you can get

What classes of weight loss medication does the program offer?
Is the medication an approved branded product, an approved generic or compounded?
How is dosing managed and adjusted?
Is the program transparent about medication sourcing?

5What members say

This pillar is the program's public Trustpilot rating, mapped straight to our 0-10 scale (a 4.5 out of 5 becomes a 9.0). It measures member satisfaction with the program, not clinical outcomes.

What is the program's current TrustScore on Trustpilot, across how many reviews?
The score on every row links to that program's Trustpilot page so you can read the reviews yourself.
Some programs have no Trustpilot profile. We label those "no Trustpilot profile" rather than invent a number, and the pillar leans on other public member feedback instead.
For big-box retailers we score the service-specific Trustpilot profile where one exists (for example Amazon Pharmacy), not the parent store's general retail rating.

See the 24 scored programs, ranked on the five dimensions above.

How we collect data

We check pricing and policies every Monday. When a site blocks automated access, we confirm the figure through a web search of the program's own materials. An Estimated mark means the program publishes no maintenance price. We do not create accounts, purchase medication or make payments to pull a price.

We do not pay for reviews or solicit them.

Price receipts

Since September 3, 2026 the price check opens the source page in a real browser and leaves a receipt behind. A receipt is one file: the figures read off the page that day, each number still attached to the label it sat under, plus the URL the browser landed on.

Each program page shows the date we saved the page its price came from.

To see a receipt, email hello@glpchart.com with the program name and we will send the file.

Evidence standard

Our educational pages make clinical claims: side-effect rates, dose schedules, what a drug label warns about. Every one has to link to the document it came from, and that document has to be a primary source. That means an FDA label or safety communication, a study on PubMed or through its DOI, a ClinicalTrials.gov record, a CMS or Medicare page, a state Medicaid policy, guidance published by a medical society, regulator or public health agency, or the manufacturer's own published document. We do not cite a news story about a study in place of the study.

Pages that meet the standard end with a Sources box and an "Evidence checked" date: the day John Samaras last walked the list against the documents. A deploy gate checks the published page, not the draft. If the box ships without a primary-source link, or the stamp lands on a day that is not a Monday, the build fails.

We have no medical reviewer on staff. What makes these pages checkable is the standard itself, not a paid sign-off.

None of this is medical advice. Take it to a prescriber before you act on it.

What we don't do

We do not let programs approve content before publication.
We do not change rankings in exchange for payment, sponsorship or marketing partnerships.
We do not remove unfavorable information at a program's request unless it is factually incorrect.
We do not present compounded medications as FDA-approved or vice versa. The regulatory status of every option is labeled clearly.

A state pharmacy-board sanction, an FDA action over product safety or quality, an active FTC enforcement action, or a verified pattern of patient harm delists a program. A warning letter over marketing claims does not. The record stays in our files and counts in the vetting checks. Listings and rankings never change for commercial reasons. When a sourced enforcement action or investigation directly challenges something we score, such as billing, cancellation or clinical intake, we lower that sub-score while the matter is unresolved. If it resolves in the program's favor, the sub-score goes back.

Update cadence

Full re-scores happen quarterly, or whenever a program announces a material change to its pricing, lock-in terms or medication availability.

What changed on this page

September 5, 2026. All five criteria were renamed to the words readers use, in two passes the same day. "Pricing transparency" became "How clear the price is" and "Onboarding experience" became "How fast you start"; later that evening "Cancellation terms" became "How easy it is to cancel", "Medication options" became "What drugs you can get" and "Member reviews" became "What members say". Each one now opens on the question a reader is actually asking. Only the names moved. The questions under each heading, every published score, the CSV column names and the anchors on this page are unchanged, so an old link to #pricing, #cancellation, #onboarding, #medication or #outcomes still lands where it did.

Get in touch

Questions, errors or methodology suggestions: hello@glpchart.com